NETRIS Pharma from France bags €7.5M extension to develop Therapeutic Molecules to treat Cancer
NETRIS Pharma, a French clinical-stage biopharmaceutical startup, has raised an additional €7.5 million in its ongoing Series A round, bringing the total to €24.4 million. This funding, which includes an investment from the EIC Fund, will be used for clinical development and corporate growth.
As we step into 2024, the realm of Artificial Intelligence (AI) continues to evolve at a breathtaking pace, reshaping industries and revolutionizing our daily lives. The past years have been marked by significant strides in AI, but what does the future hold? In this article, we delve into the top

The best Articles in our Network

Previous
Next